Holding website  

  • About Us
    • What we do
      • Strategic Approach
    • Management Team
    • Collaboration & Partnering
    • Investors
    • Careers
      • Open Positions
        • Head of Medical Affairs
    • Privacy
  • APR Products
    • Prescription Healthcare Products
      • PKU GOLIKE® Family
      • Nexodyn® – Advanced Wound Care
        • Tehclo Technology
      • Diclofenac Immediate Release
        • Immediate Release Technology
        • Diclofenac 50 mg products
      • Ondansetron ODF
        • ODF Technology
        • Ondansetron ODF products
      • APR TD011 – Epidermolysis Bullosa
        • Tehclo Technology
      • APR TD012 – Hailey Hailey Disease
        • Tehclo Technology
      • APR 1204 – Ocular Surface Diseases
        • Tehclo Technology
      • Exelya®
        • Exelya®
        • Tehclo Technology
    • Consumer Healthcare Products
      • Acute Pain
        • Diclofenac 25 mg products
      • Healthy Aging – SwitzAge™
      • Pediatric
        • Halykoo
    • Therapeutical Areas
      • Inherited Metabolic Disorders
        • What is PKU (Phenylketonuria)?
      • Advanced Wound Care
        • Unmet Medical Need
      • Cancer Supportive Care
        • Nausea and vomiting
        • Oncodermatology
      • CNS (migraine)
      • Rare Dermatological Diseases
        • Epidermolysis Bullosa
        • Hailey Hailey Disease
      • Eye laser surgery
    • Pipeline
  • Our Services
    • Solid Dosage Forms
      • Oral Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Oral Nutraceuticals
        • Integrated project development
        • Project design planning
      • Oral Medical Devices
        • Integrated project development
        • Project design planning
    • Non-Solid Dosage Forms
      • Topical Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Topical Dermocosmetics
        • Integrated project development
        • Project design planning
      • Topical Medical Devices
        • Integrated project development
        • Project design planning
    • Analytical Services
    • Certifications
  • Media
    • Presentations
    • Press Releases
  • Contacts
    • Location
    • Vigilance
    • APR LAB

Discover who we are and our partners global network, as well as learn more about our people.

Learn more about our products and how they provide innovative solutions for patiens' unmet needs.

Discover our capabilities in project design services.

Find information such as website news, press releases and event presentations.

Get in touch with us to set up a meeting or propose your cooperation.

 
Management Team

Holding website  

  • About Us
    • What we do
      • Strategic Approach
    • Management Team
    • Collaboration & Partnering
    • Investors
    • Careers
      • Open Positions
        • Head of Medical Affairs
    • Privacy
  • APR Products
    • Prescription Healthcare Products
      • PKU GOLIKE® Family
      • Nexodyn® – Advanced Wound Care
        • Tehclo Technology
      • Diclofenac Immediate Release
        • Immediate Release Technology
        • Diclofenac 50 mg products
      • Ondansetron ODF
        • ODF Technology
        • Ondansetron ODF products
      • APR TD011 – Epidermolysis Bullosa
        • Tehclo Technology
      • APR TD012 – Hailey Hailey Disease
        • Tehclo Technology
      • APR 1204 – Ocular Surface Diseases
        • Tehclo Technology
      • Exelya®
        • Exelya®
        • Tehclo Technology
    • Consumer Healthcare Products
      • Acute Pain
        • Diclofenac 25 mg products
      • Healthy Aging – SwitzAge™
      • Pediatric
        • Halykoo
    • Therapeutical Areas
      • Inherited Metabolic Disorders
        • What is PKU (Phenylketonuria)?
      • Advanced Wound Care
        • Unmet Medical Need
      • Cancer Supportive Care
        • Nausea and vomiting
        • Oncodermatology
      • CNS (migraine)
      • Rare Dermatological Diseases
        • Epidermolysis Bullosa
        • Hailey Hailey Disease
      • Eye laser surgery
    • Pipeline
  • Our Services
    • Solid Dosage Forms
      • Oral Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Oral Nutraceuticals
        • Integrated project development
        • Project design planning
      • Oral Medical Devices
        • Integrated project development
        • Project design planning
    • Non-Solid Dosage Forms
      • Topical Pharmaceuticals
        • Integrated project development
        • Project design planning
      • Topical Dermocosmetics
        • Integrated project development
        • Project design planning
      • Topical Medical Devices
        • Integrated project development
        • Project design planning
    • Analytical Services
    • Certifications
  • Media
    • Presentations
    • Press Releases
  • Contacts
    • Location
    • Vigilance
    • APR LAB

The APR's Management Team is made by highly experienced professionals covering all key areas in product development, registration and commercialization.

Paolo Galfetti

Chief Executive Officer

 

paolo.galfetti@apr.ch
Phone: +41 91 6957021
Mobile: +41 79 9163215
vCard

CEO and Member of the Board of Directors. Mr. Galfetti holds a bachelor degree in economics from the Commercial University Bocconi in Milan, Italy. He has in addition achieved the distinction of CFA (Chartered Financial Accountant). Mr. Galfetti gained practical and managerial experience in a number of sectors such as clinical research, pharmaceutical discovery and development, business development and licensing as well as operational strategic management and restructuring. Mr. Galfetti joined APR in 1995 as head of licensing and business development and was appointed to his current position in 2002. Mr. Galfetti is member of several Pharma Licensing groups and has been a speaker at a number of international conferences in the pharmaceutical field.

paolo.galfetti@apr.ch
Phone: +41 91 6957021
Mobile: +41 79 9163215
vCard

Giorgio Reiner

Corporate Director, R&D

 

giorgio.reiner@apr.ch
Phone: +41 91 6957023
Mobile: +41 79 9163216
vCard

Chief Scientific Officer (CSO) and Head of Research & Development Operations. Mr. Reiner holds a graduate degree in pharmaceutical chemistry and technology from the University of Pharmacy in Milan, Italy. He has completed post graduate courses in toxicology as well as in cosmetic technology. Mr. Reiner is author of scientific publications and inventor or co-inventor of several patents covering synthesis processes, drug delivery technologies and pharmaceutical compositions and formulations. He has over 25 years of work experience in Research and Development in areas including organic drug synthesis, pharmaceutical process development and analytical control. Mr. Reiner has joined APR in 2000 and currently serves as Chief Scientific Officer (CSO) and Head of Research & Development Operations.

giorgio.reiner@apr.ch
Phone: +41 91 6957023
Mobile: +41 79 9163216
vCard

Giulia Recalcati

Corporate Director, Finance

 

Mrs. Recalcati holds a Bachelor's Degree in Economics and Finance from the Commercial University Bocconi and a Master's Degree in Economics from the University Cattolica (Milan). She started her career as External Auditor at PricewaterhouseCoopers S.p.A. in Milan providing assurance and consulting services to large retailers and pharmaceutical companies. Afterwards, she worked as Internal Auditor in an Apparel company managing financial, compliance and operational audit projects. She joined APR in 2018 and now is responsible for Finance activities.

Daniele Contento

Operations & Sales Director

 

vCard

Mr. Contento holds a Master's Degree in Engineering Management. All his professional experience took place in the pharmaceutical industry, covering various roles in Purchasing and Planning areas and afterwards in Supply Chain Management area.

Mr. Contento joined APR in 2020 as Head of Supply Chain and was appointed to his current position during 2021.

vCard

Alessandra Frangi

Technical Operations Director
GMP/GDP Responsible Person

 

Mrs Frangi holds a Bachelor's Degree in Biological Sciences from the University La Statale (Milan). She gained 20 years practical and managerial experience working in the pharmaceutical quality control and manufacturing, managing microbiological and chemical GMP laboratories in international Companies.

She is a qualified Auditor and has been working as Quality System consultant with pharmaceutical, medical devices, cosmetics, food supplements companies and contract testing laboratories, achieving a wide experience as project leader and trainer.

She joined APR in 2015 and currently serves as GMP/GDP Technical Responsible and Director of Technical Operations, responsible of the technical department and the laboratories of APR, covering Research and Development, Manufacturing and Quality Control Functions.

Vincenzo Gallo

Corporate Legal Counsel

 

vCard

Mr. Gallo achieved a Master’s degree in Law summa cum laude from University “Magna Graecia” of Catanzaro, Italy in 2012 and he qualified to practice Law in Italy in 2014. He has been working as in-house legal counsel in international pharmaceutical groups since 2013, covering roles of increasing responsibilities and leading the legal activities in certain geographical areas.

Mr. Gallo joined APR as Corporate Legal Counsel in May 2020. He is responsible for legal and compliance matters, acts as Privacy Manager and representative for Trademarks management. He is completing an Executive Master in Compliance, Risk & Business Continuity Management & Auditing at ISTUM (Italy).

vCard

Nadia Giarratana

Pre-Clinical & Clinical Operations Director
Head of Regulatory Medical Device

 

nadia.giarratana@apr.ch

Mrs. Giarratana holds a graduate degree in Medical Biotechnologies from the University of Studies in Milan and a PhD in Cellular & Molecular Biology and Pathology from the University of Verona. She attended several advanced courses in pre-clinical/clinical area and a high specialization course in regulatory affairs. Actively partecipating in the strategic design and development, from idea to commercialization, of several products belonging to different regulatory categories, Mrs. Giarratana gained practical and managerial experience in pre/clinical operations of Pharmaceutical Products, Medical Devices, Medical Foods and in the regulatory development of Medical Devices from class I to class III. She is co-author of more than 20 scientific publications. Mrs. Giarratana joined APR in 2004 after an experience in Roche Milano Ricerche and in Bioxell; her current position is Pre-Clinical & Clinical Operations Director, and Head of Regulatory Medical Device.

nadia.giarratana@apr.ch

Patrizia Marzorati

Head of Medical Affairs

 

Mrs. Marzorati holds a bachelor degree in Medical Biotechnology at University of Milan (Italy) and a PhD in Cellular and Molecular Biology at San Raffaele Hospital in Milan as a research scientists in stem cells. A Master in marketing e management in the pharmaceutical field completes her background.

Her scientific preparation is the starting point of the experience as Regulatory Affairs, Project Manager then evolved into Innovation Project Manager.

She joined APR in 2010 and now is responsible for Medical Affairs keeping in this role also the scientific strategic analyses for internal and external new projects and LCM.

Stefano Balestrini

Business Development & Licensing Director

 

Mr Balestrini joined APR in 2022 as In-Licensed Manager with the responsibility to focus on the acquisition of assets in rare diseases and since January 2024 Mr Balestrini has progressed to Business Development & Licensing Director, with responsibility of licensing-out proprietary and legacy products, divest non-core assets, looking at alternative ways to raise cash for corporate R&D programs, looking after the in-licensing strategy.

Prior to APR, Mr Balestrini held various International commercial roles for 13+ years working for medium to large pharmaceutical organizations in several different geographies (Ireland, Russia, France, Czech Republic, Switzerland). He holds a BA in Business from Bocconi University, an MA in International Management from Regent’s College, London and an MBA from Imperial College, London.

What we do Collaboration & Partnering
APR 2015 all rights reserved | About us | APR Products | Our services | News & Events | Contact | Privacy policy | Cookie policy | Sitemap